+Compare
CVRX
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
315.09M

CVRX CVRx Forecast, Technical & Fundamental Analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for CVRX with price predictions
08:00 PM EDT Sep 28, 2023

CVRX's RSI Indicator ascends from oversold territory

The RSI Indicator for CVRX moved out of oversold territory on September 26, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 12 similar instances when the indicator left oversold territory. In of the 12 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 29, 2023. You may want to consider a long position or call options on CVRX as a result. In of 40 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CVRX just turned positive on September 29, 2023. Looking at past instances where CVRX's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVRX advanced for three days, in of 131 cases, the price rose further within the following month. The odds of a continued upward trend are .

CVRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

CVRX moved below its 50-day moving average on September 07, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CVRX crossed bearishly below the 50-day moving average on September 12, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CVRX entered a downward trend on September 29, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.503) is normal, around the industry mean (24.898). P/E Ratio (0.182) is within average values for comparable stocks, (79.320). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.382). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (10.163) is also within normal values, averaging (58.126).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.32B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -8%. FEMY experienced the highest price growth at 868%, while AVGR experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 137%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was 149%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 67
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

CVRX is expected to report earnings to rise 3.91% to -58 cents per share on November 01

CVRx CVRX Stock Earnings Reports
Q3'23
Est.
$-0.58
Q2'23
Beat
by $0.02
Q1'23
Beat
by $0.02
Q4'22
Beat
by $0.05
Q3'22
Beat
by $0.07
The last earnings report on July 25 showed earnings per share of -56 cents, beating the estimate of -57 cents. With 63.65K shares outstanding, the current market capitalization sits at 315.09M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
9201 West Broadway Avenue
Phone
+1 763 416-2840
Employees
160
Web
https://www.cvrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRGCX6.100.02
+0.33%
DWS RREEF Global Real Estate Secc C
JHCPX12.570.02
+0.16%
JHFunds2 Capital Appreciation NAV
TGBLX8.90-0.01
-0.11%
T. Rowe Price Global Impact Equity I
PFGRX27.27-0.10
-0.37%
Pioneer Fundamental Growth R
DNSMX17.06-0.13
-0.76%
Driehaus Small Cap Growth Institutional

CVRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVRX has been closely correlated with STRRP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVRX jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVRX
1D Price
Change %
CVRX100%
-0.07%
STRRP - CVRX
67%
Closely correlated
+2.81%
OLK - CVRX
31%
Poorly correlated
-0.41%
AXNX - CVRX
31%
Poorly correlated
-1.54%
RVTY - CVRX
29%
Poorly correlated
+0.41%
DXCM - CVRX
28%
Poorly correlated
-2.26%
More

Groups containing CVRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVRX
1D Price
Change %
CVRX100%
-0.07%
CVRX
(undefined stocks)
93%
Closely correlated
+1.37%
Medical Specialties
(undefined stocks)
26%
Poorly correlated
+0.46%
Medical Specialties
(undefined stocks)
26%
Poorly correlated
+0.46%